These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 17190910

  • 21. Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications.
    Noh H, Yu MR, Kim HJ, Lee JH, Park BW, Wu IH, Matsumoto M, King GL.
    Kidney Int; 2017 Jul; 92(1):101-113. PubMed ID: 28396116
    [Abstract] [Full Text] [Related]

  • 22. Critical role for osteopontin in diabetic nephropathy.
    Nicholas SB, Liu J, Kim J, Ren Y, Collins AR, Nguyen L, Hsueh WA.
    Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
    [Abstract] [Full Text] [Related]

  • 23. Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.
    Lee FT, Cao Z, Long DM, Panagiotopoulos S, Jerums G, Cooper ME, Forbes JM.
    J Am Soc Nephrol; 2004 Aug; 15(8):2139-51. PubMed ID: 15284299
    [Abstract] [Full Text] [Related]

  • 24. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
    Zhang J, Zhang Y, Xiao F, Liu Y, Wang J, Gao H, Rong S, Yao Y, Li J, Xu G.
    Biochem Pharmacol; 2016 Feb 01; 101():100-11. PubMed ID: 26673543
    [Abstract] [Full Text] [Related]

  • 25. Protective effect of the nuclear factor kappa B inhibitor pyrrolidine dithiocarbamate in lung injury in rats with streptozotocin-induced diabetes.
    Eren G, Cukurova Z, Hergunsel O, Demir G, Kucur M, Uslu E, Dalo E, Uhri M, Tugcu V.
    Respiration; 2010 Feb 01; 79(5):402-10. PubMed ID: 19996572
    [Abstract] [Full Text] [Related]

  • 26. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
    Ndisang JF, Jadhav A.
    Endocrinology; 2014 Jan 01; 155(1):215-29. PubMed ID: 24140713
    [Abstract] [Full Text] [Related]

  • 27. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG, Lin H, Qi XM, Wu GZ, Qian H, Zhao M, Shen JJ, Lin ST.
    Int Immunopharmacol; 2006 Mar 01; 6(3):445-53. PubMed ID: 16428080
    [Abstract] [Full Text] [Related]

  • 28. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy.
    Ahad A, Ganai AA, Mujeeb M, Siddiqui WA.
    Chem Biol Interact; 2014 Aug 05; 219():64-75. PubMed ID: 24877639
    [Abstract] [Full Text] [Related]

  • 29. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B, Zhang Y, Liu G, Guan GJ, Hou XH, Li XG, Liu JL.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):540-5. PubMed ID: 18649770
    [Abstract] [Full Text] [Related]

  • 30. Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.
    Abd El Motteleb DM, Abd El Aleem DI.
    Clin Exp Pharmacol Physiol; 2017 Apr 26; 44(4):509-521. PubMed ID: 28079268
    [Abstract] [Full Text] [Related]

  • 31. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J, Wang P, Ying J, Chen Z, Yu S.
    Cell Physiol Biochem; 2016 Apr 26; 39(3):1196-208. PubMed ID: 27595397
    [Abstract] [Full Text] [Related]

  • 32. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
    Chen KH, Hung CC, Hsu HH, Jing YH, Yang CW, Chen JK.
    Chem Biol Interact; 2011 Mar 15; 190(1):45-53. PubMed ID: 21300041
    [Abstract] [Full Text] [Related]

  • 33. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis.
    Xu P, Zhou XJ, Chen LQ, Chen J, Xie Y, Lv LH, Hou XH.
    World J Gastroenterol; 2007 Apr 07; 13(13):1983-8. PubMed ID: 17461502
    [Abstract] [Full Text] [Related]

  • 34. Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway.
    Gbr AA, Abdel Baky NA, Mohamed EA, Zaky HS.
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb 07; 394(2):349-360. PubMed ID: 32984914
    [Abstract] [Full Text] [Related]

  • 35. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB, Paramar AN, Balaraman R.
    Cardiovasc Res; 2005 Apr 01; 66(1):150-61. PubMed ID: 15769458
    [Abstract] [Full Text] [Related]

  • 36. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats.
    Konturek PC, Brzozowski T, Burnat G, Szlachcic A, Koziel J, Kwiecien S, Konturek SJ, Harsch IA.
    J Physiol Pharmacol; 2010 Aug 01; 61(4):429-36. PubMed ID: 20814070
    [Abstract] [Full Text] [Related]

  • 37. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    Liu W, Zhang X, Liu P, Shen X, Lan T, Li W, Jiang Q, Xie X, Huang H.
    Eur J Pharmacol; 2010 Jul 25; 638(1-3):150-5. PubMed ID: 20447389
    [Abstract] [Full Text] [Related]

  • 38. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL, Xu M, Wei C, Qin AP, Liu CF, Hong LZ, Zhao XY, Liu J, Qin ZH.
    Neuroscience; 2011 Mar 10; 176():381-95. PubMed ID: 21185913
    [Abstract] [Full Text] [Related]

  • 39. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
    Zhu L, Han J, Yuan R, Xue L, Pang W.
    Biol Res; 2018 Mar 31; 51(1):9. PubMed ID: 29604956
    [Abstract] [Full Text] [Related]

  • 40. [The effect of inhibiting nuclear factor-kappa B on the diabetic nephropathy].
    Ding H, Li F, Xu M, Deng Y, Deng Q, Zhu Z, Cheng H, Fu Z, Wang Y.
    Zhonghua Nei Ke Za Zhi; 2002 Sep 31; 41(9):605-9. PubMed ID: 12421493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.